BLCO · Bausch + Lomb Corporation Common Shares
View on chartInsiders & Stakes
| Bausch Health Companies Inc. 10% Owner | ▼ Sell | Open Market | 310,449,643 Shares held | 6/1/2022 | View profile |
| Brent L. Saunders Director | ▲ Buy | Grant | 1,256,037 Shares held | 8/5/2026 | View profile |
| Joseph C. Papa President and CEO | ▲ Buy | Grant | 472,222 Shares held | 5/5/2022 | View profile |
| Sam Eldessouky EVP & Chief Financial Officer | ▲ Buy | Grant | 393,527 Shares held | 8/5/2026 | View profile |
| A. Robert D. Bailey EVP & Chief Legal Officer | ▲ Buy | Grant | 264,241 Shares held | 8/5/2026 | View profile |
| Yehia Hashad EVP, R&D and CMO | ▲ Buy | Grant | 187,350 Shares held | 8/5/2026 | View profile |
| ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | ▲ Buy | Grant | 146,677 Shares held | 3/1/2023 | View profile |
| Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | ▲ Buy | Grant | 125,702 Shares held | 3/1/2023 | View profile |
| Luc Bonnefoy President,Surgical | ▲ Buy | Grant | 103,801 Shares held | 8/5/2026 | View profile |
| Andrew J. Stewart See remarks | ▲ Buy | Grant | 103,211 Shares held | 8/5/2026 | View profile |
| Russel C. Robertson Director | ▲ Buy | Grant | 94,260 Shares held | 5/26/2026 | View profile |
| John Paulson Director | ▲ Buy | Grant | 89,823 Shares held | 5/26/2026 | View profile |
| Nathalie D. Bernier Director | ▲ Buy | Grant | 85,505 Shares held | 5/26/2026 | View profile |
| Thomas W. Ross Sr. Director | ▲ Buy | Grant | 85,233 Shares held | 5/26/2026 | View profile |
| Sarah B. Kavanagh Director | ▲ Buy | Grant | 69,541 Shares held | 5/26/2026 | View profile |
| VON ESCHENBACH ANDREW C. Director | ▼ Sell | Open Market | 63,733 Shares held | 8/7/2026 | View profile |
| Karen Ling Director | ▲ Buy | Grant | 61,518 Shares held | 5/26/2026 | View profile |
| Brett Icahn Director | ▲ Buy | Grant | 61,147 Shares held | 5/27/2025 | View profile |
| Hu Gaoxiang Director | ▲ Buy | Grant | 61,147 Shares held | 5/27/2025 | View profile |
| Frederick Munsch SVP, Controller and CAO | ▼ Sell | Open Market | 45,831 Shares held | 8/10/2026 | View profile |
| Steven H. Collis Director | ▲ Buy | Grant | 42,003 Shares held | 5/26/2026 | View profile |
| DE SCHUTTER RICHARD U Director | ▲ Buy | Grant | 32,952 Shares held | 3/29/2024 | View profile |
| Eduardo Alfonso Director | ▲ Buy | Grant | 31,072 Shares held | 5/26/2026 | View profile |
| Laurence E. Paul Director | ▲ Buy | Grant | 11,776 Shares held | 8/12/2026 | View profile |
| Barbara Trebbi Director | ▲ Buy | Grant | 11,776 Shares held | 8/12/2026 | View profile |
| Robert J. Chersi Director | ▲ Buy | Grant | 11,776 Shares held | 8/12/2026 | View profile |
Transaction History
| Barbara Trebbi | ▲ Buy | Grant | 11,776 | $0 | 8/12/2026 |
| Laurence E. Paul | ▲ Buy | Grant | 11,776 | $0 | 8/12/2026 |
| Robert J. Chersi | ▲ Buy | Grant | 11,776 | $0 | 8/12/2026 |
| Frederick Munsch | ▼ Sell | Open Market | 52,900 | $888K | 8/10/2026 |
| VON ESCHENBACH ANDREW C. | ▼ Sell | Open Market | 6,059 | $100K | 8/7/2026 |
| VON ESCHENBACH ANDREW C. | ▼ Sell | Open Market | 12,500 | $206K | 8/6/2026 |
| Brent L. Saunders | ▼ Sell | Tax Withholding | 4,231 | $71K | 8/5/2026 |
| Andrew J. Stewart | ▲ Buy | Grant | 16,778 | $0 | 8/5/2026 |
| Frederick Munsch | ▲ Buy | Grant | 9,091 | $0 | 8/5/2026 |
| Yehia Hashad | ▲ Buy | Grant | 20,973 | $0 | 8/5/2026 |
| Sam Eldessouky | ▲ Buy | Grant | 50,335 | $0 | 8/5/2026 |
| Luc Bonnefoy | ▲ Buy | Grant | 16,778 | $0 | 8/5/2026 |
| A. Robert D. Bailey | ▲ Buy | Grant | 33,557 | $0 | 8/5/2026 |
| Brent L. Saunders | ▲ Buy | Grant | 281,879 | $0 | 8/5/2026 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 1,008 | $15K | 6/12/2026 |
| Eduardo Alfonso | ▲ Buy | Grant | 15,842 | $250K | 5/26/2026 |
| Steven H. Collis | ▲ Buy | Grant | 15,842 | $250K | 5/26/2026 |
| VON ESCHENBACH ANDREW C. | ▲ Buy | Grant | 15,842 | $250K | 5/26/2026 |
| Thomas W. Ross Sr. | ▲ Buy | Grant | 15,842 | $250K | 5/26/2026 |
| Russel C. Robertson | ▲ Buy | Grant | 15,842 | $250K | 5/26/2026 |
| John Paulson | ▲ Buy | Grant | 15,842 | $250K | 5/26/2026 |
| Karen Ling | ▲ Buy | Grant | 15,842 | $250K | 5/26/2026 |
| Sarah B. Kavanagh | ▲ Buy | Grant | 15,842 | $250K | 5/26/2026 |
| Nathalie D. Bernier | ▲ Buy | Grant | 15,842 | $250K | 5/26/2026 |
| Brent L. Saunders | ▼ Sell | Tax Withholding | 2,886 | $46K | 5/22/2026 |
| Sam Eldessouky | ▼ Sell | Tax Withholding | 63,938 | $1.0M | 5/5/2026 |
| Yehia Hashad | ▼ Sell | Tax Withholding | 13,664 | $219K | 5/5/2026 |
| Frederick Munsch | ▼ Sell | Tax Withholding | 8,673 | $139K | 5/5/2026 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 11,970 | $192K | 5/5/2026 |
| Russel C. Robertson | ▲ Buy | Grant | 1,611 | $26K | 4/30/2026 |
| John Paulson | ▲ Buy | Grant | 1,375 | $22K | 4/30/2026 |
| Steven H. Collis | ▲ Buy | Grant | 1,415 | $22K | 4/30/2026 |
| Eduardo Alfonso | ▲ Buy | Grant | 1,375 | $22K | 4/30/2026 |
| Andrew J. Stewart | ▼ Sell | Tax Withholding | 4,216 | $67K | 4/24/2026 |
| A. Robert D. Bailey | ▼ Sell | Tax Withholding | 15,806 | $250K | 4/24/2026 |
| A. Robert D. Bailey | ▲ Buy | Open Market | 14,600 | $250K | 3/6/2026 |
| A. Robert D. Bailey | ▲ Buy | Grant | 14,600 | $0 | 3/6/2026 |
| Sam Eldessouky | ▲ Buy | Open Market | 4,000 | $69K | 3/6/2026 |
| Sam Eldessouky | ▲ Buy | Grant | 4,000 | $0 | 3/6/2026 |
| Brent L. Saunders | ▲ Buy | Open Market | 14,700 | $252K | 3/6/2026 |
| Brent L. Saunders | ▲ Buy | Grant | 14,700 | $0 | 3/6/2026 |
| Thomas W. Ross Sr. | ▲ Buy | Open Market | 4,500 | $80K | 3/3/2026 |
| Thomas W. Ross Sr. | ▲ Buy | Grant | 4,500 | $0 | 3/3/2026 |
| Eduardo Alfonso | ▲ Buy | Open Market | 4,300 | $77K | 3/2/2026 |
| Eduardo Alfonso | ▲ Buy | Grant | 4,300 | $0 | 3/2/2026 |
| VON ESCHENBACH ANDREW C. | ▲ Buy | Open Market | 4,364 | $80K | 2/27/2026 |
| VON ESCHENBACH ANDREW C. | ▲ Buy | Grant | 4,364 | $0 | 2/27/2026 |
| Frederick Munsch | ▼ Sell | Tax Withholding | 2,437 | $45K | 2/27/2026 |
| Frederick Munsch | ▼ Sell | Tax Withholding | 5,692 | $104K | 2/27/2026 |
| Andrew J. Stewart | ▼ Sell | Tax Withholding | 2,007 | $37K | 2/27/2026 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 4,311 | $79K | 2/27/2026 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 9,221 | $169K | 2/27/2026 |
| Yehia Hashad | ▼ Sell | Tax Withholding | 5,075 | $93K | 2/27/2026 |
| Yehia Hashad | ▼ Sell | Tax Withholding | 11,621 | $213K | 2/27/2026 |
| A. Robert D. Bailey | ▼ Sell | Tax Withholding | 2,461 | $45K | 2/27/2026 |
| Sam Eldessouky | ▼ Sell | Tax Withholding | 15,507 | $284K | 2/27/2026 |
| Sam Eldessouky | ▼ Sell | Tax Withholding | 51,470 | $942K | 2/27/2026 |
| Brent L. Saunders | ▼ Sell | Tax Withholding | 24,649 | $451K | 2/27/2026 |
| Frederick Munsch | ▼ Sell | Tax Withholding | 2,042 | $38K | 2/26/2026 |
| Andrew J. Stewart | ▼ Sell | Tax Withholding | 2,984 | $55K | 2/26/2026 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 4,404 | $81K | 2/26/2026 |
| Yehia Hashad | ▼ Sell | Tax Withholding | 2,169 | $40K | 2/26/2026 |
| A. Robert D. Bailey | ▼ Sell | Tax Withholding | 3,395 | $63K | 2/26/2026 |
| Sam Eldessouky | ▼ Sell | Tax Withholding | 7,062 | $131K | 2/26/2026 |
| Brent L. Saunders | ▼ Sell | Tax Withholding | 22,059 | $408K | 2/26/2026 |
| Yehia Hashad | ▲ Buy | Grant | 35,046 | $0 | 2/25/2026 |
| A. Robert D. Bailey | ▲ Buy | Grant | 52,570 | $0 | 2/25/2026 |
| Sam Eldessouky | ▲ Buy | Grant | 81,775 | $0 | 2/25/2026 |
| Frederick Munsch | ▲ Buy | Grant | 18,253 | $0 | 2/25/2026 |
| Luc Bonnefoy | ▲ Buy | Grant | 30,373 | $0 | 2/25/2026 |
| Andrew J. Stewart | ▲ Buy | Grant | 32,710 | $0 | 2/25/2026 |
| Brent L. Saunders | ▲ Buy | Grant | 327,102 | $0 | 2/25/2026 |
| Brent L. Saunders | ▼ Sell | Tax Withholding | 65,444 | $1.2M | 2/23/2026 |
| Steven H. Collis | ▲ Buy | Open Market | 15,000 | $267K | 2/23/2026 |
| Steven H. Collis | ▲ Buy | Grant | 4,491 | $0 | 2/23/2026 |
| Russel C. Robertson | ▲ Buy | Open Market | 4,400 | $79K | 2/20/2026 |
| Russel C. Robertson | ▲ Buy | Grant | 4,400 | $0 | 2/20/2026 |
| Karen Ling | ▲ Buy | Open Market | 4,000 | $71K | 2/19/2026 |
| Karen Ling | ▲ Buy | Grant | 4,000 | $0 | 2/19/2026 |
| Steven H. Collis | ▲ Buy | Grant | 5,255 | $0 | 2/19/2026 |
| Eduardo Alfonso | ▲ Buy | Grant | 5,255 | $0 | 2/19/2026 |
| Russel C. Robertson | ▲ Buy | Grant | 1,451 | $26K | 2/19/2026 |
| John Paulson | ▲ Buy | Grant | 1,239 | $22K | 2/19/2026 |
| Luc Bonnefoy | ▲ Buy | Grant | 10,202 | $0 | 2/18/2026 |
| Frederick Munsch | ▲ Buy | Grant | 12,498 | $0 | 2/18/2026 |
| Yehia Hashad | ▲ Buy | Grant | 29,406 | $0 | 2/18/2026 |
| Sam Eldessouky | ▲ Buy | Grant | 70,578 | $0 | 2/18/2026 |
| Russel C. Robertson | ▲ Buy | Grant | 1,642 | $26K | 11/14/2025 |
| John Paulson | ▲ Buy | Grant | 1,402 | $22K | 11/14/2025 |
| Brent L. Saunders | ▼ Sell | Tax Withholding | 4,231 | $61K | 8/5/2025 |
| Frederick Munsch | ▲ Buy | Grant | 7,529 | $0 | 8/5/2025 |
| Sam Eldessouky | ▲ Buy | Grant | 42,517 | $0 | 8/5/2025 |
| Luc Bonnefoy | ▲ Buy | Grant | 6,146 | $0 | 8/5/2025 |
| Yehia Hashad | ▲ Buy | Grant | 17,715 | $0 | 8/5/2025 |
| Yehia Hashad | ▼ Sell | Tax Withholding | 2,841 | $41K | 7/25/2025 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 2,167 | $31K | 7/25/2025 |
| Frederick Munsch | ▼ Sell | Tax Withholding | 1,090 | $16K | 7/25/2025 |
| Sam Eldessouky | ▼ Sell | Tax Withholding | 3,996 | $57K | 7/25/2025 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 968 | $12K | 6/13/2025 |
| VON ESCHENBACH ANDREW C. | ▲ Buy | Grant | 20,338 | $0 | 5/27/2025 |
| Thomas W. Ross Sr. | ▲ Buy | Grant | 20,338 | $0 | 5/27/2025 |
| Russel C. Robertson | ▲ Buy | Grant | 20,338 | $0 | 5/27/2025 |
| John Paulson | ▲ Buy | Grant | 20,338 | $0 | 5/27/2025 |
| Karen Ling | ▲ Buy | Grant | 20,338 | $0 | 5/27/2025 |
| Sarah B. Kavanagh | ▲ Buy | Grant | 20,338 | $0 | 5/27/2025 |
| Brett Icahn | ▲ Buy | Grant | 20,338 | $0 | 5/27/2025 |
| Hu Gaoxiang | ▲ Buy | Grant | 20,338 | $0 | 5/27/2025 |
| Nathalie D. Bernier | ▲ Buy | Grant | 20,338 | $0 | 5/27/2025 |
| Brent L. Saunders | ▲ Buy | Open Market | 22,000 | $248K | 5/22/2025 |
| Brent L. Saunders | ▲ Buy | Grant | 22,000 | $0 | 5/22/2025 |
| VON ESCHENBACH ANDREW C. | ▲ Buy | Open Market | 1,695 | $20K | 5/2/2025 |
| Russel C. Robertson | ▲ Buy | Grant | 2,210 | $26K | 5/1/2025 |
| John Paulson | ▲ Buy | Grant | 1,887 | $22K | 5/1/2025 |
| Andrew J. Stewart | ▼ Sell | Tax Withholding | 3,954 | $55K | 4/24/2025 |
| A. Robert D. Bailey | ▼ Sell | Tax Withholding | 9,781 | $136K | 4/24/2025 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 1,110 | $18K | 2/28/2025 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 3,029 | $48K | 2/28/2025 |
| Frederick Munsch | ▲ Buy | Grant | 18,581 | $0 | 2/26/2025 |
| Luc Bonnefoy | ▲ Buy | Grant | 23,423 | $0 | 2/26/2025 |
| Andrew J. Stewart | ▲ Buy | Grant | 23,423 | $0 | 2/26/2025 |
| Yehia Hashad | ▲ Buy | Grant | 25,225 | $0 | 2/26/2025 |
| A. Robert D. Bailey | ▲ Buy | Grant | 40,540 | $0 | 2/26/2025 |
| Sam Eldessouky | ▲ Buy | Grant | 59,459 | $0 | 2/26/2025 |
| Brent L. Saunders | ▲ Buy | Grant | 168,168 | $0 | 2/26/2025 |
| Frederick Munsch | ▼ Sell | Tax Withholding | 908 | $16K | 12/23/2024 |
| Andrew J. Stewart | ▼ Sell | Tax Withholding | 2,524 | $45K | 12/23/2024 |
| Brent L. Saunders | ▼ Sell | Tax Withholding | 73,782 | $1.3M | 12/23/2024 |
| Brent L. Saunders | ▼ Sell | Tax Withholding | 24,649 | $439K | 12/23/2024 |
| Frederick Munsch | ▼ Sell | Tax Withholding | 2,192 | $39K | 12/23/2024 |
| Yehia Hashad | ▼ Sell | Tax Withholding | 2,324 | $41K | 12/23/2024 |
| Yehia Hashad | ▼ Sell | Tax Withholding | 2,751 | $49K | 12/23/2024 |
| Sam Eldessouky | ▼ Sell | Tax Withholding | 7,249 | $129K | 12/23/2024 |
| Sam Eldessouky | ▼ Sell | Tax Withholding | 8,582 | $153K | 12/23/2024 |
| A. Robert D. Bailey | ▼ Sell | Tax Withholding | 4,402 | $78K | 12/23/2024 |
| Russel C. Robertson | ▲ Buy | Grant | 1,328 | $26K | 9/30/2024 |
| John Paulson | ▲ Buy | Grant | 1,134 | $22K | 9/30/2024 |
| Brent L. Saunders | ▲ Buy | Open Market | 32,250 | $505K | 8/5/2024 |
| Brent L. Saunders | ▲ Buy | Grant | 32,250 | $0 | 8/5/2024 |
| VON ESCHENBACH ANDREW C. | ▲ Buy | Grant | 14,696 | $0 | 8/2/2024 |
| Thomas W. Ross Sr. | ▲ Buy | Grant | 14,696 | $0 | 8/2/2024 |
| Russel C. Robertson | ▲ Buy | Grant | 14,696 | $0 | 8/2/2024 |
| John Paulson | ▲ Buy | Grant | 14,696 | $0 | 8/2/2024 |
| Karen Ling | ▲ Buy | Grant | 14,696 | $0 | 8/2/2024 |
| Sarah B. Kavanagh | ▲ Buy | Grant | 14,696 | $0 | 8/2/2024 |
| Brett Icahn | ▲ Buy | Grant | 14,696 | $0 | 8/2/2024 |
| Hu Gaoxiang | ▲ Buy | Grant | 14,696 | $0 | 8/2/2024 |
| Nathalie D. Bernier | ▲ Buy | Grant | 14,696 | $0 | 8/2/2024 |
| Yehia Hashad | ▼ Sell | Tax Withholding | 2,841 | $44K | 7/25/2024 |
| Frederick Munsch | ▼ Sell | Tax Withholding | 1,313 | $20K | 7/25/2024 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 2,144 | $33K | 7/25/2024 |
| Sam Eldessouky | ▼ Sell | Tax Withholding | 5,113 | $79K | 7/25/2024 |
| John Paulson | ▲ Buy | Grant | 1,506 | $22K | 6/28/2024 |
| Russel C. Robertson | ▲ Buy | Grant | 1,764 | $26K | 6/28/2024 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 958 | $14K | 6/14/2024 |
| Andrew J. Stewart | ▼ Sell | Tax Withholding | 3,943 | $59K | 4/24/2024 |
| A. Robert D. Bailey | ▼ Sell | Tax Withholding | 9,838 | $147K | 4/24/2024 |
| Russel C. Robertson | ▲ Buy | Grant | 1,481 | $26K | 3/29/2024 |
| John Paulson | ▲ Buy | Grant | 1,264 | $22K | 3/29/2024 |
| DE SCHUTTER RICHARD U | ▲ Buy | Grant | 1,553 | $27K | 3/29/2024 |
| Karen Ling | ▲ Buy | Grant | 2,642 | $0 | 3/5/2024 |
| Yehia Hashad | ▼ Sell | Tax Withholding | 2,143 | $35K | 3/1/2024 |
| Frederick Munsch | ▼ Sell | Tax Withholding | 995 | $16K | 3/1/2024 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 1,098 | $18K | 3/1/2024 |
| Sam Eldessouky | ▼ Sell | Tax Withholding | 4,854 | $80K | 3/1/2024 |
| Frederick Munsch | ▲ Buy | Grant | 18,183 | $0 | 2/28/2024 |
| Yehia Hashad | ▲ Buy | Grant | 20,973 | $0 | 2/28/2024 |
| Luc Bonnefoy | ▲ Buy | Grant | 16,778 | $0 | 2/28/2024 |
| Andrew J. Stewart | ▲ Buy | Grant | 16,778 | $0 | 2/28/2024 |
| Sam Eldessouky | ▲ Buy | Grant | 50,335 | $0 | 2/28/2024 |
| Brent L. Saunders | ▲ Buy | Grant | 187,919 | $0 | 2/28/2024 |
| A. Robert D. Bailey | ▲ Buy | Grant | 33,557 | $0 | 2/28/2024 |
| Russel C. Robertson | ▲ Buy | Grant | 1,502 | $26K | 12/29/2023 |
| John Paulson | ▲ Buy | Grant | 1,282 | $22K | 12/29/2023 |
| DE SCHUTTER RICHARD U | ▲ Buy | Grant | 1,575 | $27K | 12/29/2023 |
| Nathalie D. Bernier | ▲ Buy | Grant | 1,465 | $25K | 12/29/2023 |
| Russel C. Robertson | ▲ Buy | Grant | 1,511 | $26K | 9/29/2023 |
| John Paulson | ▲ Buy | Grant | 1,290 | $22K | 9/29/2023 |
| DE SCHUTTER RICHARD U | ▲ Buy | Grant | 1,585 | $27K | 9/29/2023 |
| Nathalie D. Bernier | ▲ Buy | Grant | 1,474 | $25K | 9/29/2023 |
| Frederick Munsch | ▼ Sell | Tax Withholding | 1,313 | $26K | 7/25/2023 |
| Yehia Hashad | ▼ Sell | Tax Withholding | 3,996 | $79K | 7/25/2023 |
| Luc Bonnefoy | ▼ Sell | Tax Withholding | 2,240 | $44K | 7/25/2023 |
| Sam Eldessouky | ▼ Sell | Tax Withholding | 4,218 | $84K | 7/25/2023 |
| Russel C. Robertson | ▲ Buy | Grant | 1,276 | $26K | 6/30/2023 |
| John Paulson | ▲ Buy | Grant | 1,089 | $22K | 6/30/2023 |
| DE SCHUTTER RICHARD U | ▲ Buy | Grant | 1,339 | $27K | 6/30/2023 |
| Nathalie D. Bernier | ▲ Buy | Grant | 1,245 | $25K | 6/30/2023 |
| Luc Bonnefoy | ▲ Buy | Grant | 5,361 | $0 | 6/14/2023 |
| VON ESCHENBACH ANDREW C. | ▲ Buy | Grant | 12,857 | $0 | 5/4/2023 |
| Thomas W. Ross Sr. | ▲ Buy | Grant | 12,857 | $0 | 5/4/2023 |
| Russel C. Robertson | ▲ Buy | Grant | 12,857 | $0 | 5/4/2023 |
| John Paulson | ▲ Buy | Grant | 12,857 | $0 | 5/4/2023 |
| Sarah B. Kavanagh | ▲ Buy | Grant | 12,857 | $0 | 5/4/2023 |
| Brett Icahn | ▲ Buy | Grant | 12,857 | $0 | 5/4/2023 |
| Hu Gaoxiang | ▲ Buy | Grant | 12,857 | $0 | 5/4/2023 |
| DE SCHUTTER RICHARD U | ▲ Buy | Grant | 12,857 | $0 | 5/4/2023 |
| Nathalie D. Bernier | ▲ Buy | Grant | 12,857 | $0 | 5/4/2023 |
| Andrew J. Stewart | ▲ Buy | Grant | 33,150 | $0 | 4/24/2023 |
| A. Robert D. Bailey | ▲ Buy | Grant | 120,500 | $0 | 4/24/2023 |
| Russel C. Robertson | ▼ Sell | Tax Withholding | 6,692 | $115K | 4/24/2023 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
BLCO Advances Oral Dry AMD Treatment After FDA Meeting
Bausch + Lomb reported progress on a new oral drug for dry age‑related macular degeneration after a constructive meeting with the FDA. The company said the discussion helped clarify the regulatory pathway and the drug’s development plan. It also announced that its third‑quarter 2026 earnings will be released on Oct. 28, giving investors a future update on performance.
BLCO Advances Oral Dry AMD Treatment After FDA Meeting. Bausch + Lomb reported progress on a new oral drug for dry age‑related macular degeneration after a constructive meeting with the FDA. The company said the discussion helped clarify the regulatory pathway and the drug’s development plan. It also announced that its third‑quarter 2026 earnings will be released on Oct. 28, giving investors a future update on performance.